$SRPT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sarepta Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sarepta Therapeutics, Inc.. Get notifications about new insider transactions in Sarepta Therapeutics, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 29 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.83 | 8,101 | 14,825 | 424,744 | 432.8 K to 424.7 K (-1.87 %) |
Jul 29 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.82 | 35,200 | 64,064 | 432,845 | 468 K to 432.8 K (-7.52 %) |
Jul 29 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.82 | 30,000 | 54,582 | 468,045 | 498 K to 468 K (-6.02 %) |
Jul 29 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.81 | 70,000 | 126,700 | 498,045 | 568 K to 498 K (-12.32 %) |
Jul 29 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Buy | M | 1.09 | 183,486 | 200,000 | 568,045 | 384.6 K to 568 K (+47.71 %) |
Jul 26 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Option Exercise | M | 1.45 | 205,400 | 297,830 | 60,118 | |
Jul 26 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.80 | 205,400 | 369,720 | 384,559 | 590 K to 384.6 K (-34.82 %) |
Jul 26 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Buy | M | 1.45 | 205,400 | 297,830 | 589,959 | 384.6 K to 590 K (+53.41 %) |
Jul 19 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Option Exercise | M | 1.09 | 100,028 | 109,031 | 0 | |
Jul 19 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.89 | 46,800 | 88,452 | 384,559 | 431.4 K to 384.6 K (-10.85 %) |
Jul 19 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.85 | 11,191 | 20,703 | 431,359 | 442.6 K to 431.4 K (-2.53 %) |
Jul 19 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.86 | 400 | 742 | 442,550 | 443 K to 442.6 K (-0.09 %) |
Jul 19 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.91 | 4,070 | 7,774 | 442,950 | 447 K to 443 K (-0.91 %) |
Jul 19 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.89 | 200 | 377 | 447,020 | 447.2 K to 447 K (-0.04 %) |
Jul 19 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.86 | 9,200 | 17,112 | 447,220 | 456.4 K to 447.2 K (-2.02 %) |
Jul 19 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.88 | 28,167 | 52,954 | 456,420 | 484.6 K to 456.4 K (-5.81 %) |
Jul 19 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Buy | M | 1.09 | 100,028 | 109,031 | 484,587 | 384.6 K to 484.6 K (+26.01 %) |
Jul 23 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Option Exercise | M | 1.45 | 265,517 | 385,000 | 265,518 | |
Jul 23 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.81 | 12,013 | 21,744 | 384,559 | 396.6 K to 384.6 K (-3.03 %) |
Jul 23 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.80 | 199,708 | 359,474 | 396,572 | 596.3 K to 396.6 K (-33.49 %) |
Jul 23 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.79 | 53,796 | 96,295 | 596,280 | 650.1 K to 596.3 K (-8.28 %) |
Jul 23 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Buy | M | 1.45 | 265,517 | 385,000 | 650,076 | 384.6 K to 650.1 K (+69.04 %) |
Jul 12 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Option Exercise | M | 1.09 | 50,000 | 54,500 | 100,028 | |
Jul 12 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Option Exercise | M | 1.09 | 150,000 | 163,500 | 150,028 | |
Jul 12 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.61 | 37,500 | 60,375 | 384,559 | 422.1 K to 384.6 K (-8.89 %) |
Jul 12 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.62 | 10,000 | 16,200 | 422,059 | 432.1 K to 422.1 K (-2.31 %) |
Jul 12 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.63 | 2,500 | 4,075 | 432,059 | 434.6 K to 432.1 K (-0.58 %) |
Jul 12 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Buy | M | 1.09 | 50,000 | 54,500 | 434,559 | 384.6 K to 434.6 K (+13.00 %) |
Jul 12 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.58 | 7,700 | 12,166 | 384,559 | 392.3 K to 384.6 K (-1.96 %) |
Jul 12 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.57 | 136,300 | 213,991 | 392,259 | 528.6 K to 392.3 K (-25.79 %) |
Jul 12 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.55 | 4,000 | 6,200 | 528,559 | 532.6 K to 528.6 K (-0.75 %) |
Jul 12 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.56 | 2,000 | 3,120 | 532,559 | 534.6 K to 532.6 K (-0.37 %) |
Jul 12 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Buy | M | 1.09 | 150,000 | 163,500 | 534,559 | 384.6 K to 534.6 K (+39.01 %) |
Jul 08 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Option Exercise | M | 0.92 | 200,000 | 184,000 | 0 | |
Jul 08 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.50 | 5,000 | 7,500 | 384,559 | 389.6 K to 384.6 K (-1.28 %) |
Jul 08 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.46 | 74,365 | 108,573 | 389,559 | 463.9 K to 389.6 K (-16.03 %) |
Jul 08 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.45 | 83,097 | 120,491 | 463,924 | 547 K to 463.9 K (-15.19 %) |
Jul 08 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.47 | 10,038 | 14,756 | 547,021 | 557.1 K to 547 K (-1.80 %) |
Jul 08 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.48 | 27,500 | 40,700 | 557,059 | 584.6 K to 557.1 K (-4.70 %) |
Jul 08 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Buy | M | 0.92 | 200,000 | 184,000 | 584,559 | 384.6 K to 584.6 K (+52.01 %) |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Option Exercise | M | 0.92 | 128,911 | 118,598 | 221,089 | |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.60 | 1,500 | 2,400 | 384,559 | 386.1 K to 384.6 K (-0.39 %) |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.59 | 3,700 | 5,883 | 386,059 | 389.8 K to 386.1 K (-0.95 %) |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.58 | 6,341 | 10,019 | 389,759 | 396.1 K to 389.8 K (-1.60 %) |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.57 | 48,928 | 76,817 | 396,100 | 445 K to 396.1 K (-10.99 %) |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.56 | 21,172 | 33,028 | 445,028 | 466.2 K to 445 K (-4.54 %) |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.55 | 47,270 | 73,269 | 466,200 | 513.5 K to 466.2 K (-9.21 %) |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Buy | M | 0.92 | 128,911 | 118,598 | 513,470 | 384.6 K to 513.5 K (+33.52 %) |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.24 | 51,338 | 63,659 | 384,559 | 435.9 K to 384.6 K (-11.78 %) |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.49 | 21,427 | 31,926 | 435,897 | 457.3 K to 435.9 K (-4.69 %) |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Option Exercise | M | 0.92 | 21,089 | 19,402 | 200,000 | |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.56 | 8,289 | 12,931 | 384,559 | 392.8 K to 384.6 K (-2.11 %) |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.49 | 4,800 | 7,152 | 392,848 | 397.6 K to 392.8 K (-1.21 %) |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.54 | 2,070 | 3,188 | 397,648 | 399.7 K to 397.6 K (-0.52 %) |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Sell | S | 1.55 | 5,930 | 9,192 | 399,718 | 405.6 K to 399.7 K (-1.46 %) |
Jul 07 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Former CEO | Buy | M | 0.92 | 21,089 | 19,402 | 405,648 | 384.6 K to 405.6 K (+5.48 %) |
Jun 11 2010 | SRPT | Sarepta Therapeuti ... | Price Ben Gil | Director | Buy | P | 1.44 | 7,000 | 10,080 | 98,982 | 92 K to 99 K (+7.61 %) |
Jun 10 2010 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Buy | P | 1.42 | 31,800 | 45,156 | 391,467 | 359.7 K to 391.5 K (+8.84 %) |
Jun 10 2010 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Buy | P | 1.42 | 300 | 426 | 359,667 | 359.4 K to 359.7 K (+0.08 %) |
Jun 10 2010 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Buy | P | 1.42 | 100 | 142 | 359,367 | 359.3 K to 359.4 K (+0.03 %) |
Jun 10 2010 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Buy | P | 1.42 | 700 | 994 | 359,267 | 358.6 K to 359.3 K (+0.20 %) |
Jun 10 2010 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Buy | P | 1.42 | 6,900 | 9,791 | 358,567 | 351.7 K to 358.6 K (+1.96 %) |
Jun 10 2010 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Buy | P | 1.42 | 100 | 142 | 351,667 | 351.6 K to 351.7 K (+0.03 %) |
Jun 10 2010 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Buy | P | 1.40 | 5,600 | 7,840 | 351,567 | 346 K to 351.6 K (+1.62 %) |
Jun 10 2010 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Buy | P | 1.40 | 1,000 | 1,399 | 345,967 | 345 K to 346 K (+0.29 %) |
Jun 09 2010 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | A | 1.30 | 60,000 | 78,000 | 60,000 | |
Jun 09 2010 | SRPT | Sarepta Therapeuti ... | Price Ben Gil | Director | Option Exercise | A | 1.30 | 30,000 | 39,000 | 30,000 | |
Jun 09 2010 | SRPT | Sarepta Therapeuti ... | Price Ben Gil | Director | Grant | A | 0.00 | 5,000 | 0 | 91,982 | 87 K to 92 K (+5.75 %) |
Jun 09 2010 | SRPT | Sarepta Therapeuti ... | HODGMAN JOHN | Director | Option Exercise | A | 1.30 | 30,000 | 39,000 | 30,000 | |
Jun 09 2010 | SRPT | Sarepta Therapeuti ... | HODGMAN JOHN | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
Jun 09 2010 | SRPT | Sarepta Therapeuti ... | Goolsbee William Alden | Director | Option Exercise | A | 1.30 | 30,000 | 39,000 | 30,000 | |
Jun 09 2010 | SRPT | Sarepta Therapeuti ... | Goolsbee William Alden | Director | Grant | A | 0.00 | 5,000 | 0 | 15,000 | 10 K to 15 K (+50.00 %) |
Jun 09 2010 | SRPT | Sarepta Therapeuti ... | Christopher Nishan Garabedian | Director | Option Exercise | A | 1.30 | 60,000 | 78,000 | 60,000 | |
Jun 09 2010 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | A | 1.30 | 30,000 | 39,000 | 30,000 | |
Jun 09 2010 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
May 24 2010 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Buy | P | 1.33 | 50,000 | 66,500 | 344,967 | 295 K to 345 K (+16.95 %) |
May 18 2010 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Buy | P | 1.44 | 10,568 | 15,218 | 294,967 | 284.4 K to 295 K (+3.72 %) |
May 18 2010 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Buy | P | 1.41 | 500 | 705 | 284,399 | 283.9 K to 284.4 K (+0.18 %) |
May 18 2010 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Buy | P | 1.41 | 18,539 | 26,140 | 283,899 | 265.4 K to 283.9 K (+6.99 %) |
May 14 2010 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Buy | P | 1.35 | 96,000 | 129,600 | 265,360 | 169.4 K to 265.4 K (+56.68 %) |
May 13 2010 | SRPT | Sarepta Therapeuti ... | Price Ben Gil | Director | Buy | P | 1.36 | 40,000 | 54,400 | 126,982 | 87 K to 127 K (+45.99 %) |
Apr 22 2010 | SRPT | Sarepta Therapeuti ... | BOYLE J DAVID II | CEO | Option Exercise | A | 1.24 | 50,000 | 62,000 | 50,000 | |
Apr 22 2010 | SRPT | Sarepta Therapeuti ... | CHASE ANTHONY R | Director | Option Exercise | A | 1.24 | 60,000 | 74,400 | 60,000 | |
Mar 10 2010 | SRPT | Sarepta Therapeuti ... | BOYLE J DAVID II | CFO | Option Exercise | A | 1.30 | 90,000 | 117,000 | 90,000 | |
Mar 10 2010 | SRPT | Sarepta Therapeuti ... | BOYLE J DAVID II | CFO | Option Exercise | A | 1.30 | 10,000 | 13,000 | 10,000 | |
Mar 08 2010 | SRPT | Sarepta Therapeuti ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 1.24 | 4,094,646 | 5,077,361 | 5,659,211 | 9.8 M to 5.7 M (-41.98 %) |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | WELLER DWIGHT D | Sr. VP Chemistry & ... | Option Exercise | J | 5.75 | 31,827 | 183,005 | 0 | |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | WELLER DWIGHT D | Sr. VP Chemistry & ... | Option Exercise | A | 1.45 | 9,425 | 13,666 | 9,425 | |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | WELLER DWIGHT D | Sr. VP Chemistry & ... | Option Exercise | A | 1.49 | 14,000 | 20,860 | 14,000 | |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | WELLER DWIGHT D | Sr. VP Chemistry & ... | Option Exercise | J | 5.75 | 52,173 | 299,995 | 0 | |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | WELLER DWIGHT D | Sr. VP Chemistry & ... | Option Exercise | A | 1.45 | 110,575 | 160,334 | 110,575 | |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | SHREWSBURY STEPHEN B | SVP/Regulatory Affa ... | Option Exercise | A | 1.45 | 120,000 | 174,000 | 120,000 | |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | SHREWSBURY STEPHEN B | SVP/Regulatory Affa ... | Option Exercise | A | 1.45 | 60,000 | 87,000 | 60,000 | |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | Medeiros Paul | SVP Business Develo ... | Option Exercise | A | 1.45 | 120,000 | 174,000 | 120,000 | |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | Medeiros Paul | SVP Business Develo ... | Option Exercise | A | 1.45 | 60,000 | 87,000 | 60,000 | |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | IVERSEN PATRICK L | Sr VP of Research & ... | Option Exercise | A | 1.45 | 16,150 | 23,418 | 16,150 | |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | IVERSEN PATRICK L | Sr VP of Research & ... | Option Exercise | A | 1.45 | 103,850 | 150,583 | 103,850 | |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | kole Ryszard | SVP/Discovery Resea ... | Option Exercise | A | 1.45 | 72,816 | 105,583 | 72,816 | |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | kole Ryszard | SVP/Discovery Resea ... | Option Exercise | A | 1.45 | 47,184 | 68,417 | 47,184 | |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Option Exercise | A | 1.45 | 531,035 | 770,001 | 531,035 | ||
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Option Exercise | A | 1.45 | 68,965 | 99,999 | 68,965 | ||
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | BOYLE J DAVID II | CFO | Option Exercise | A | 1.45 | 82,759 | 120,001 | 82,759 | |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | BOYLE J DAVID II | CFO | Option Exercise | J | 1.21 | 150,000 | 181,500 | 102,068 | |
Feb 11 2010 | SRPT | Sarepta Therapeuti ... | BOYLE J DAVID II | CFO | Option Exercise | A | 1.45 | 97,241 | 140,999 | 97,241 | |
Nov 13 2009 | SRPT | Sarepta Therapeuti ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 1.45 | 5,100 | 7,395 | 13,890,188 | 13.9 M to 13.9 M (-0.04 %) |
Nov 13 2009 | SRPT | Sarepta Therapeuti ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 1.43 | 12,000 | 17,100 | 13,895,288 | 13.9 M to 13.9 M (-0.09 %) |
Nov 13 2009 | SRPT | Sarepta Therapeuti ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 1.41 | 33,450 | 47,161 | 13,907,288 | 13.9 M to 13.9 M (-0.24 %) |
Nov 13 2009 | SRPT | Sarepta Therapeuti ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 1.42 | 283,400 | 401,436 | 13,940,738 | 14.2 M to 13.9 M (-1.99 %) |
Aug 25 2009 | SRPT | Sarepta Therapeuti ... | HAYWOOD GEORGE WEAVER | Option Exercise | P | 1.78 | 400,000 | 712,000 | 400,000 | ||
Aug 25 2009 | SRPT | Sarepta Therapeuti ... | HAYWOOD GEORGE WEAVER | Buy | P | 0.00 | 400,000 | 0 | 8,213,717 | 7.8 M to 8.2 M (+5.12 %) | |
Aug 25 2009 | SRPT | Sarepta Therapeuti ... | HAYWOOD GEORGE WEAVER | Buy | P | 1.35 | 30,000 | 40,500 | 7,813,717 | 7.8 M to 7.8 M (+0.39 %) | |
Aug 25 2009 | SRPT | Sarepta Therapeuti ... | HAYWOOD GEORGE WEAVER | Buy | P | 1.39 | 450,000 | 625,500 | 7,783,717 | 7.3 M to 7.8 M (+6.14 %) | |
May 21 2009 | SRPT | Sarepta Therapeuti ... | Goolsbee William Alden | Director | Option Exercise | A | 1.10 | 20,000 | 22,000 | 20,000 | |
May 21 2009 | SRPT | Sarepta Therapeuti ... | Goolsbee William Alden | Director | Option Exercise | H | 5.00 | 500 | 2,500 | 0 | |
May 21 2009 | SRPT | Sarepta Therapeuti ... | Goolsbee William Alden | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
May 21 2009 | SRPT | Sarepta Therapeuti ... | Price Ben Gil | Director | Option Exercise | A | 1.10 | 20,000 | 22,000 | 20,000 | |
May 21 2009 | SRPT | Sarepta Therapeuti ... | Price Ben Gil | Director | Grant | A | 0.00 | 5,000 | 0 | 86,982 | 82 K to 87 K (+6.10 %) |
May 21 2009 | SRPT | Sarepta Therapeuti ... | HODGMAN JOHN | Director | Option Exercise | A | 1.10 | 20,000 | 22,000 | 20,000 | |
May 21 2009 | SRPT | Sarepta Therapeuti ... | HODGMAN JOHN | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
May 21 2009 | SRPT | Sarepta Therapeuti ... | FORREST K MICHAEL | Outside Director | Option Exercise | A | 1.10 | 20,000 | 22,000 | 20,000 | |
May 21 2009 | SRPT | Sarepta Therapeuti ... | FORREST K MICHAEL | Outside Director | Grant | A | 0.00 | 5,000 | 0 | 15,000 | 10 K to 15 K (+50.00 %) |
May 21 2009 | SRPT | Sarepta Therapeuti ... | CASEY MICHAEL D | Director | Option Exercise | A | 1.10 | 20,000 | 22,000 | 20,000 | |
May 21 2009 | SRPT | Sarepta Therapeuti ... | CASEY MICHAEL D | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Apr 02 2009 | SRPT | Sarepta Therapeuti ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 0.66 | 60,000 | 39,600 | 60,000 | |
May 20 2009 | SRPT | Sarepta Therapeuti ... | Medeiros Paul | SVP/Business Develo ... | Option Exercise | A | 1.10 | 127,273 | 140,000 | 127,273 | |
May 20 2009 | SRPT | Sarepta Therapeuti ... | Medeiros Paul | SVP/Business Develo ... | Option Exercise | A | 1.10 | 272,727 | 300,000 | 272,727 | |
Apr 02 2009 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | A | 0.66 | 60,000 | 39,600 | 60,000 | |
Mar 17 2009 | SRPT | Sarepta Therapeuti ... | Price Ben Gil | Director | Buy | P | 0.67 | 20,400 | 13,703 | 81,982 | 61.6 K to 82 K (+33.13 %) |
Mar 17 2009 | SRPT | Sarepta Therapeuti ... | Price Ben Gil | Director | Buy | P | 0.65 | 30,000 | 19,377 | 61,582 | 31.6 K to 61.6 K (+94.99 %) |
Mar 13 2009 | SRPT | Sarepta Therapeuti ... | BOYLE J DAVID II | CFO | Buy | P | 0.64 | 19,000 | 12,145 | 65,282 | 46.3 K to 65.3 K (+41.05 %) |
Feb 13 2009 | SRPT | Sarepta Therapeuti ... | kole Ryszard | SVP/Discovery Resea ... | Option Exercise | A | 0.92 | 100,000 | 92,000 | 100,000 | |
Feb 13 2009 | SRPT | Sarepta Therapeuti ... | kole Ryszard | SVP/Discovery Resea ... | Grant | A | 0.00 | 21,432 | 0 | 1,862,926 | 1.8 M to 1.9 M (+1.16 %) |
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Option Exercise | A | 1.09 | 300,028 | 327,031 | 300,028 | ||
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Option Exercise | A | 0.92 | 350,000 | 322,000 | 350,000 | ||
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Option Exercise | A | 1.09 | 366,972 | 399,999 | 366,972 | ||
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Grant | A | 0.00 | 124,324 | 0 | 457,324 | 333 K to 457.3 K (+37.33 %) | |
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | Hudson Leslie | Grant | A | 0.00 | 333,000 | 0 | 333,000 | 0 to 333 K | |
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | BOYLE J DAVID II | CFO | Option Exercise | A | 0.92 | 100,000 | 92,000 | 100,000 | |
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | BOYLE J DAVID II | CFO | Option Exercise | A | 0.92 | 50,000 | 46,000 | 50,000 | |
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | BOYLE J DAVID II | CFO | Grant | A | 0.00 | 46,282 | 0 | 46,282 | 0 to 46.3 K |
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | WELLER DWIGHT D | Sr. VP Chemistry & ... | Option Exercise | A | 0.92 | 6,161 | 5,668 | 6,161 | |
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | WELLER DWIGHT D | Sr. VP Chemistry & ... | Option Exercise | J | 4.34 | 2,682 | 11,640 | 0 | |
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | WELLER DWIGHT D | Sr. VP Chemistry & ... | Option Exercise | J | 3.81 | 10,000 | 38,100 | 0 | |
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | WELLER DWIGHT D | Sr. VP Chemistry & ... | Option Exercise | A | 0.92 | 93,839 | 86,332 | 93,839 | |
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | WELLER DWIGHT D | Sr. VP Chemistry & ... | Grant | A | 0.00 | 28,919 | 0 | 314,741 | 285.8 K to 314.7 K (+10.12 %) |
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | IVERSEN PATRICK L | Sr VP of Research & ... | Option Exercise | A | 0.92 | 33,333 | 30,666 | 33,333 | |
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | IVERSEN PATRICK L | Sr VP of Research & ... | Option Exercise | A | 0.92 | 66,667 | 61,334 | 66,667 | |
Feb 12 2009 | SRPT | Sarepta Therapeuti ... | IVERSEN PATRICK L | Sr VP of Research & ... | Grant | A | 0.00 | 31,545 | 0 | 86,303 | 54.8 K to 86.3 K (+57.61 %) |
Jan 28 2009 | SRPT | Sarepta Therapeuti ... | SHREWSBURY STEPHEN B | SVP/Regulatory Affa ... | Option Exercise | A | 1.36 | 229,413 | 312,002 | 229,413 | |
Jan 28 2009 | SRPT | Sarepta Therapeuti ... | SHREWSBURY STEPHEN B | SVP/Regulatory Affa ... | Option Exercise | A | 1.36 | 220,587 | 299,998 | 220,587 |